The global pharmaceutical industry – in the land of shrinking giants. 1. Introduction The case describes the evolution of the industry and its unusual strategic environment. Attention is drawn to environmental pressures from regulators and payers. Key forces driving the industry are discussed‚ including addressing unmet medical need‚ the importance of innovation and time to market‚ and globalisation. The case illustrates how an increasingly hostile environment‚ combined with a decline in R&D
Premium Strategic management Industry Management
PHARMACEUTIC ALS INDUSTRY ANALYSIS GROUP MEMBERS: MANVI KARTHIKEYA VAMSI VINOD INDUSTRY ANALYSIS The Indian Pharmaceutical industry today is in the front rank of India’s science based industries with wide range capabilities in the complex field of drugs and technology. MARKET SIZE It ranks 4th in the world pertaining to the Volume of sales. Estimated worth of Indian Pharmaceuticals Industry is US$ 6 billion Almost 70% of domestic demand for bulk drugs is catered by Indian Pharma Industry Growth
Premium Pharmaceutical industry Pharmacology
Three brothers‚ Robert Wood Johnson‚ James Wood Johnson and Edward Mead Johnson‚ found Johnson & Johnson in 1886. Johnson & Johnson (J&J) is a global American pharmaceutical‚ medical device and consumer packaged goods manufacturer. The corporation’s headquarters is located in New Brunswick‚ New Jersey. Johnson & Johnson‚ together with its specific divisions‚ engages in the research and development‚ manufacture‚ and sale of various products in the health care field worldwide. Its Consumer segment
Premium Medicine Johnson & Johnson Health care
1.Intro: A pharmaceutical drug (medicine or medication and officially medicinal product) is any chemical substance formulated or compounded as single active ingredient or in combination of other pharmacologically active substance‚ it may be in a separate but packed in a single unit pack as combination product intended for internal‚ or external or for use in the medical diagnosis‚ cure‚ treatment‚ or prevention of disease. 2. History: The development of small molecule therapeutic agents for
Premium Pharmacology Drug discovery
environment‚ extending its shelf life. The whole manufacturing process deals with the following steps:- 1. Lab testing of pharmaceutical ingredients 2. Manufacturing of tablets (Granulation and Compression) 3. Coating of Tablets 4. Lab testing of tablets 5. Packaging and Sealing Lab Testing of Raw-Materials (pharmaceutical ingredients) The tests and assays described are the official methods upon which the standards of Pharmacopoeia are based. Alternative
Premium Tablet
339-360 15 Helfat C.E.‚ Raubitscek R.S.‚ (2000)‚ ‘Product sequencing: co-evolution of knowledge‚ capabilities and products’‚ Strategic Management Journal‚ 21‚ 961-979 Henderson R.‚ Clark K.‚ (1994)‚ ‘Measuring competence? Exploring firm effects on pharmaceutical research’‚ Strategic Management Journal‚ 16‚ 63-84 Hitt M.A.‚ Bierman L.‚ Shimizu K.‚ Kochlar R.‚ (2001b)‚ ‘Direct and moderating effects of human capital on strategy and performance in professional service firms: a resourcebased perspective’
Premium Management Strategic management Innovation
The Global Pharmaceutical Industry: Swallowing a Bitter Pill The case describes the evolution of the pharmaceutical industry and its strategic environment. Attention is drawn to environmental pressures from regulators and payers. Key forces driving the industry are discussed‚ including addressing unmet medical needs‚ the importance of innovation and time to market‚ and globalisation. The case illustrates how an increasingly hostile environment‚ combined with a decline in R&D productivity‚ led
Premium Medicine Pharmacology Industry
of the pharmaceutical market creates a conflict between the competing interests of the patients and the pharmaceutical industry where the increasing market expansion and profitability of the industry is happening at the cost of patients’ ability to receive the most appropriate and effective treatment. The interests of the Pharmaceutical industry outcompeted the interests of patients and public health providers by the increased integration and resulting influence of the pharmaceutical industry in all
Premium Health care Pharmaceutical industry Clinical trial
1.1 OVERVIEW: Trade Related Aspects of Intellectual property Rights was put into effect in the developed countries since Jan 1996. And it will be implemented in Less Developed Countries starting from Jan 2006. Egypt is preparing its pharmaceutical industry for such agreement. A sense of optimism is expressed in the rich North. While a sense of pessimism is expressed in the poor South. Research and Development companies feel quite secure. Reverse Engineering companies (producing imitated products)
Premium Patent
BRANDING STRATEGIES IN THE PHARMACEUTICAL INDUSTRY VERSUS FAST MOVING CONSUMER GOODS? Abstract The objective of this paper is to analyse the branding strategies used currently in the pharmaceutical industry and compare it to the best practices in Fast Moving Consumer goods. First the authors review the differences in the way branding is defined and organised in pharmaceuticals versus FMCG and identify why branding could be leveraged in the pharmaceutical industry to help it return to strong
Premium Brand Brand management Branding